Literature DB >> 9661103

Brief communication: criterion validity of the Personality Diagnostic Questionnaire-4+ (PDQ-4+) in a mixed psychiatric sample.

A Fossati1, C Maffei, M Bagnato, D Donati, M Donini, M Fiorilli, L Novella, M Ansoldi.   

Abstract

Three hundred consecutively admitted in- and outpatients were administered the Personality Diagnostic Questionnaire-4+ (PDQ-4+). The Structured Clinical Interview for DSM-IV Axis II Personality Disorders, Version 2.0 (SCID-II) was used as the external diagnostic standard for personality disorder (PD) assessment. SCID-II was administered blind to PDQ-4+ scores. Low agreement between PDQ-4+ and SCID-II was observed for both dimensional and categorical PD evaluations. Receiver operating characteristic (ROC) analysis showed a definitively satisfactory discriminatory capability only for two PDQ-4+ PD scales (dependent, and antisocial). In agreement with previous studies, these results showed that PDQ-4+ was not a substitute for a structured diagnostic interview.

Entities:  

Mesh:

Year:  1998        PMID: 9661103     DOI: 10.1521/pedi.1998.12.2.172

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  11 in total

1.  Convergent and discriminant validity of psychopathy factors assessed via self-report: a comparison of three instruments.

Authors:  Stephen D Benning; Christopher J Patrick; Randall T Salekin; Anne-Marie R Leistico
Journal:  Assessment       Date:  2005-09

2.  Assessment procedures for narcissistic personality disorder: a comparison of the personality diagnostic questionnaire-4 and best-estimate clinical judgments.

Authors:  Joshua D Miller; W Keith Campbell; Paul A Pilkonis; Jennifer Q Morse
Journal:  Assessment       Date:  2008-06-11

3.  Acute risk factors for suicide attempts and death: prospective findings from the STEP-BD study.

Authors:  Elizabeth D Ballard; Jennifer L Vande Voort; David A Luckenbaugh; Rodrigo Machado-Vieira; Mauricio Tohen; Carlos A Zarate
Journal:  Bipolar Disord       Date:  2016-05-27       Impact factor: 6.744

4.  Personality disorders in hypochondriasis: prevalence and comparison with two anxiety disorders.

Authors:  Brian A Fallon; Katy M Harper; Alla Landa; Martina Pavlicova; Franklin R Schneier; Amanda Carson; Kelli Harding; Kathryn Keegan; Theresa Schwartz; Michael R Liebowitz
Journal:  Psychosomatics       Date:  2012-05-31       Impact factor: 2.386

5.  Childhood trauma, personality disorders symptoms and current major depressive disorder in Togo.

Authors:  Kossi B Kounou; Eric Bui; Kolou S Dassa; Devon Hinton; Laura Fischer; Gnansa Djassoa; Philippe Birmes; Laurent Schmitt
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-12-07       Impact factor: 4.328

Review 6.  Excess mortality in bipolar disorders.

Authors:  Christopher Miller; Mark S Bauer
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

7.  Women with alcohol dependence: A randomized trial of couple versus individual plus couple therapy.

Authors:  Barbara S McCrady; Elizabeth E Epstein; Kevin A Hallgren; Sharon Cook; Noelle K Jensen
Journal:  Psychol Addict Behav       Date:  2016-05

8.  The relationship between self-reported borderline personality features and prospective illness course in bipolar disorder.

Authors:  Georg Riemann; Nadine Weisscher; Robert M Post; Lori Altshuler; Susan McElroy; Marc A Frye; Paul E Keck; Gabriele S Leverich; Trisha Suppes; Heinz Grunze; Willem A Nolen; Ralph W Kupka
Journal:  Int J Bipolar Disord       Date:  2017-09-25

9.  Screening cluster A and cluster B personality disorders in Chinese high school students.

Authors:  Yuping Wang; Xiongzhao Zhu; Lin Cai; Qin Wang; Mengcheng Wang; Jinyao Yi; Shuqiao Yao
Journal:  BMC Psychiatry       Date:  2013-04-17       Impact factor: 3.630

10.  Dialectical behavior therapy skills use and emotion dysregulation in personality disorders and psychopathy: a community self-report study.

Authors:  Andrada D Neacsiu; Mathew A Tkachuck
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2016-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.